New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - phenytoin sodium 100mg; phenytoin sodium 100mg; phenytoin sodium 100mg - capsule - 100 mg - active: phenytoin sodium 100mg excipient: erythrosine gelatin lactose monohydrate magnesium stearate purified talc sucrose sunset yellow fcf titanium dioxide vegetable carbon wheat starch active: phenytoin sodium 100mg excipient: erythrosine gelatin lactose monohydrate magnesium stearate maize starch purified talc sucrose sunset yellow fcf titanium dioxide vegetable carbon active: phenytoin sodium 100mg excipient: confectioner's sugar erythrosine gelatin lactose monohydrate magnesium stearate purified talc sunset yellow fcf titanium dioxide vegetable carbon - dilantin is indicated for the control of grand mal and psychomotor seizures. dilantin will prevent or effectively decrease the incidence and severity of convulsive seizures in a high percentage of cases, with patients exhibiting little tendency to become resistant to its action. besides its effectiveness in controlling seizures, dilantin frequently improves the mental condition and outlook of epileptic patients and there is also increasing evidence that dilantin is valuable in the prevention of seizures occurring during or after neurosurgery. phenytoin serum level determinations may be necessary for optimal dosage adjustments.

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - sodium valproate 100mg - tablet - 100 mg - active: sodium valproate 100mg excipient: hydrated silica light kaolin magnesium stearate maize starch purified water - epilepsy: primary generalised epilepsy (petit mal absences, various forms of myoclonic epilepsy and tonic-clonic grand mal seizures). partial (focal) epilepsy either alone or as adjuvant therapy.

New Zealand - English - Medsafe (Medicines Safety Authority)

boucher & muir (new zealand) limited t/a bnm group - flecainide acetate 100mg;   - tablet - 100 mg - active: flecainide acetate 100mg   excipient: croscarmellose sodium magnesium stearate maize starch microcrystalline cellulose pregelatinised maize starch purified water - in patients without structural heart disease and without myocardial infarction, flecainide bnm tablets are indicated for the prevention of: supraventricular arrhythmias · paroxysmal supraventricular tachycardias (psvt) including atrioventricular nodal reentrant tachycardia, atrioventricular reentrant tachycardia and other supraventricular tachycardias of unspecified mechanism associated with disabling symptoms; · paroxysmal atrial fibrillation/flutter (paf) associated with disabling symptoms. ventricular arrhythmias · documented life-threatening ventricular arrhythmias such as sustained ventricular tachycardia (vt) if they are considered life-threatening in the judgement of the attending physician. not indicated for less severe ventricular arrhythmias even if symptomatic. use of flecainide in chronic atrial fibrillation has not been adequately studied and is not recommended.

New Zealand - English - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - lamotrigine 100mg - chewable/dispersible tablet - 100 mg - active: lamotrigine 100mg excipient: aluminium magnesium silicate blackcurrant flavour 502009 ap0551 calcium carbonate hyprolose magnesium stearate povidone saccharin sodium sodium starch glycolate - epilepsy adults (over 12 years of age) lamictal is indicated as adjunctive therapy in the treatment of epilepsy, for partial seizures and generalised seizures, including tonic-clonic seizures and the seizures associated with lennox-gastaut syndrome. children (2 to 12 years of age) lamictal is indicated as adjunctive therapy in the treatment of epilepsy, for partial seizures and generalised seizures including tonic-clonic seizures and the seizures associated with lennox-gaustaut syndrome.

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - lamotrigine 100mg;  ;   - chewable/dispersible tablet - 100 mg - active: lamotrigine 100mg     excipient: blackcurrant flavour 502009 ap0551 colloidal silicon dioxide magnesium stearate mannitol microcrystalline cellulose povidone purified water saccharin sodium sodium starch glycolate - adults (over 12 years of age) logem is indicated as adjunctive therapy in the treatment of epilepsy, for partial seizures and generalized seizures, including tonic-clonic seizures and the seizures associated with lennox-gastaut syndrome. children (2 to 12 years of age) logem is indicated as adjunctive therapy in the treatment of epilepsy, for partial seizures and generalised seizures including tonic-clonic seizures and the seizures associated with lennox-gaustaut syndrome.

New Zealand - English - Medsafe (Medicines Safety Authority)

abbvie limited - ritonavir 100mg - film coated tablet - 100 mg - active: ritonavir 100mg excipient: calcium hydrogen phosphate colloidal silicon dioxide copovidone opadry white 16b18449 sodium stearyl fumarate sorbitan laurate - norvir is indicated for use in combination with appropriate antiretroviral agents or as monotherapy if combination therapy is inappropriate, for the treatment of hiv-1 infection in adults and children aged 12 years and older. for persons with advanced hiv disease, the indication for ritonavir is based on the results for one study that showed a reduction in both mortality and aids defining clinical events for patients who received ritonavir. median duration of follow-up in this study was 6 months. the clinical benefit from ritonavir for longer periods of treatment is unknown. for persons with less advanced disease, the indication is based on changes in surrogate markers in controlled trials of up to 16 weeks duration.

Singapore - English - HSA (Health Sciences Authority)

msd pharma (singapore) pte. ltd. - raltegravir potassium 108.6 mg eqv raltegravir - tablet, chewable - 100 mg - raltegravir potassium 108.6 mg eqv raltegravir 100 mg

Singapore - English - HSA (Health Sciences Authority)

viatris private limited - phenytoin sodium - capsule - 100 mg - phenytoin sodium 100 mg

Singapore - English - HSA (Health Sciences Authority)

glaxosmithkline pte ltd - lamotrigine - tablet - 100 mg - lamotrigine 100 mg

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - palbociclib 100mg - capsule - 100 mg - active: palbociclib 100mg excipient: colloidal silicon dioxide gelatin   iron oxide red   iron oxide yellow   lactose monohydrate magnesium stearate microcrystalline cellulose opacode white s-1-7085 sodium starch glycolate titanium dioxide   - ibrance is indicated for the treatment of hormone receptor (hr)-positive, human epidermal growth factor receptor 2 (her2)-negative locally advanced or metastatic breast cancer: - in combination with an aromatase inhibitor; - in combination with fulvestrant in women who have received prior endocrine therapy. in pre- or peri-menopausal women, the endocrine therapy should be combined with a luteinizing hormone-releasing hormone (lhrh) agonist.